By
Columbia University
Published: March 17, 2024, 2:18 p.m.·
Tags:
Treatment
Radiant Moms is a study that aims to explore the feasibility, acceptability, and perceived demand for the new 17-week RPT-MOX regimen (rifapentine, moxifloxacin, isoniazid and pyrazinamide) for pregnant and breastfeeding women among key stakeholders. The study has been approved by the Columbia University Irving Medical Center Institutional Review Board in the U.S. and the Stellenbosch University Research Ethics Committee in South Africa, as a collaborative project.
Read More →
